news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

[introduction] due to personal reasons, shen xinghu, chairman of hisun pharmaceutical, suddenly resigned

china fund news reporter lu yu

following the resignation of the former chairman jiang guoping,shen xinghu, chairman of hisun pharmaceuticals, also submitted his resignation for personal reasons, and after his resignation he will no longer hold any position in hisun pharmaceutical and its subsidiaries.

chairman resigns after less than a year in office

hisun pharmaceutical announced on the evening of august 28 that the board of directors received a written resignation report submitted by the company's chairman shen xinghu on august 28.

due to personal reasons, shen xinghu requested to resign from the positions of chairman of the ninth board of directors, director, member of the nomination committee, and chairman of the expert committee of the company, and will no longer serve as the legal representative of the company. after his resignation, shen xinghu will no longer hold any position in the company and its subsidiaries.

hisun pharmaceutical stated that according to the provisions of the company's articles of association, before the new chairman takes office, all directors unanimously nominated director zheng baichao to act as the chairman and legal representative; the company will complete the director by-election and chairman election as soon as possible in accordance with relevant laws and regulations.

according to information, zheng baichao is currently the director and general manager of taizhou city jiaojiang district state-owned capital operation group co., ltd., and also serves as a director of hisun pharmaceutical and hisun group.

at the end of august 2023, hisun pharmaceutical announced that jiang guoping had applied to resign from his positions as chairman of the board of directors for personal reasons. at that time, the controlling shareholder hisun group recommended shen xinghu as a candidate for replacement director and chairman.on september 19, 2023, hisun pharmaceutical announced that the board of directors elected shen xinghu as the company's chairman.

the controlling shareholder of hisun pharmaceutical is hisun group.the actual controller is taizhou jiaojiang district state-owned capital operation group co., ltd.shen xinghu was a member of the standing committee of the jiaojiang district committee of taizhou city and a member of the party leadership group of the district government. he is currently the party secretary, legal representative and chairman of hisun group.

several senior executives resigned

on april 30, 2024, hisun pharmaceutical announced that the company received a letter from the state-owned assets supervision and administration office of the people's government of jiaojiang district, taizhou city, stating that from 2019 to 2022,li yan, the company's former director and former president, is suspected of corruption, embezzlement, bribery, and bribery of non-state personnel in the company's agency business. relevant departments are currently investigating.

prior to this, on april 5, 2023, li yan resigned from the position of president of hisun pharmaceutical, and after his resignation, he will no longer hold any position in the company and its subsidiaries.it took less than a year from the time li yan resigned to the time he was notified of the investigation.

after li yan resigned, on august 31, 2023, jiang guoping, then chairman of hisun pharmaceutical, resigned and ceased to serve as the company's legal representative. chen xiaohua, vice chairman, senior vice president and acting president, also resigned at the same time. on november 29, 2023, zhang zhenying, chief financial officer of hisun pharmaceutical, resigned. after the resignation of these three people, they no longer hold any positions in hisun pharmaceutical and its subsidiaries.

in september 2023, an investor asked the secretary of the board of directors on an interactive platform, saying, "it is rumored everywhere in the market that the company's former president li yan, chairman jiang guoping, and vice president chen xiaohua have been taken away by relevant departments for inflating hanhui's assets. doesn't the company plan to issue an announcement to clarify the facts?"

in this regard, hisun pharmaceutical did not give a positive response.

as of august 28, hisun pharmaceutical's share price was 7.45 yuan, and its latest market value was 9 billion yuan.

editor: joey

review: xu wen

copyright notice

"china fund news" enjoys the copyright to the original content published on this platform. reproduction without authorization is prohibited, otherwise legal liability will be pursued.

contact person for authorized reprint cooperation: mr. yu (tel: 0755-82468670)